News & AnalysisPharvaris reels in $80m Series CPharvaris, a drug developer, has raised $80 million in Series C financing.ByIris Dorbian19 November 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs